References
- Marty M, Pouillart P, Scholl S. Comparison of the 5-hydroxytryptamine, (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990; 322: 816–821
- DeMulder P HM, Seynaeve C, Vermorken JB. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. Ann Intern Med 1990; 113: 834–840
- Beck TM, Ciociola AA, Jones SE. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. Ann Intern Med 1993; 118: 407–413
- Gralla RJ. Nausea and vomiting. Cancer: Principles and Practice of Oncology, 3rd ed. JB Lippincott, Philadelphia 1989; 2137–2144
- Cassileth PA, Lusk EJ, Torri S. Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med 1983; 143: 1347–1349
- Markman M, Sheidler V, Ettinger DS. Antiemetic efficacy of dexamethasone—Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 1984; 311: 549–552
- Jones AL, Hill AS, Soukop M. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 1991; 338: 483–486